Rechallenge of Cetuximab Combined With Irinotecan as Third-line Chemotherapy in Patients With Metastatic Colorectal Cancer - Phase II Study
Clinical trial NCT02316496 · TERMINATED
Trial details
- NCT number
- NCT02316496
- Sponsor
- GERCOR - Multidisciplinary Oncology Cooperative Group
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-23
- Primary completion
- 2016-01-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.